Podcasts about designer dna

The clever and intelligent research done by these scientists goes a long way to demonstrate that information and the machinery required to utilize it can only come about by intelligent means. This episode article was written by Dr David Catchpoole and podcast produced by Joseph Darnell out of the CMI-USA office. Become a monthly contributor at our site. You can also help out by telling your family and friends to check out the podcasts. ✍️ Links and Show Notes Original article: Designer DNA Replicating Rabbits Podcasts: What! No Potatoes? Do Any Vestigial Structures Exist in Humans? DNA: Marvellous Message or Mostly Mess? A New Cancer Treatment Thanks to Darwin? Articles DNA: the best information storage system More marvellous machinery: ‘DNA scrunching' Organized complexity—how atheistic assumptions hinder science Origin of Life Questions and Answers

We get into the topic of designer DNA and our thoughts on the topic. Sometimes things are not black and white. Join us as we get into the Gray areas. Relationships, Money, Music, Movies, Daily Routine, and lots more. We would love to hear from you. Connect with us at: Instagram: @GrayPeoplePodcast | Twitter: @GrayPplPodcast | Email: GrayPeoplePodcast@gmail.com | Youtube: https://www.youtube.com/channel/UCnYU9xSZ2lZIPnoGt4sDHWw Also, please check out our amazing friends: DRERAWKA and his podcasts at www.ALLRAWK.com Will Wonder and his podcast at www.linktr.ee/TheWillWonderPod --- Support this podcast: https://anchor.fm/graypeoplepodcast/support

The future is here, but will it be kind? Designer DNA is the way of the future. Should we be more skeptical? How does divine creation and God factor into the new era 'genetics race'? Author Jamie Metzl joins the show to discuss his new book, Hacking Darwin.  Learn more about your ad choices. Visit megaphone.fm/adchoices

We've got the hosts of Death, Sex & Money, Food 4 Thot, and Call Your Girlfriend on the show to watch and talk about three new episodes of Explained. Anna Sale wrestles with the ethical issues surrounding Designer DNA. Fran Tirado and Joseph Osmundson dissect Monogamy. And Aminatou Sow tries to figure out Cryptocurrency (so we don't have to). Plus, we brought back Sean Rameswaram to host the episode!Explained is a new pop doc series from Vox and Netflix. Each episode is a mini 15 minute documentary covering pop culture, tech, science, and beyond. All the pop docs discussed in this episode are out on Netflix now. 

In this episode Dr. Carlos Faraco speaks with Dr. Don Cleveland of the University of California San Diego regarding his work on drug-based gene silencing therapies. Cleveland and the members of his lab use these therapies, also known as designer DNA drugs, to silence genes involved in the development of various neurodegenerative diseases such as Alzheimer’s, Huntington’s and Lou Gehrig’s disease. In addition to these familiar diseases, they also discuss how designer DNA drugs may help those suffering from chronic traumatic encephalopathy, a neurodegenerative disease affecting individuals with a history of repeated head injury, including athletes, military personnel, and domestic abuse victims. While the concept of chronic traumatic encephalopathy was first introduced in the early 1900s due to its prevalence in boxers, the cause of the disease has recently come under significant public scrutiny in the US due to several high-profile stories involving football players. Participants Host: Carlos Faraco, Ph.D., Neuroscience 2016-2018 Executive Branch Fellow at the National Institutes of Justice Don Cleveland, Ph.D., Biomedical Sciences Chair, Departmental of Cellular and Molecular Medicine, UCSD Professor of Medicine, Neurosciences, and Cellular and Molecular Medicine, UCSD Member, Ludwig Institute for Cancer Research Executive Producer: Carlos Faraco, Ph.D., Neuroscience 2016-2018 Executive Branch Fellow at the National Institutes of Justice This blog does not necessarily reflect the views of AAAS, its Council, Board of Directors, officers, or members. AAAS is not responsible for the accuracy of this material. AAAS has made this material available as a public service, but this does not constitute endorsement by the association.

Can we turn off the genes responsible for neurodegenerative diseases? Designer DNA drugs are making this possible. By identifying and targeting the genes that drive disease, scientists are moving closer to treatments for ALS, Huntington's disease, and more. Don W. Cleveland, PhD, Department of Cellular and Molecular Medicine, UC San Diego joins William Mobley, MD, PhD to talk about how these drugs work and how they will impact patient care. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 32505]

Can we turn off the genes responsible for neurodegenerative diseases? Designer DNA drugs are making this possible. By identifying and targeting the genes that drive disease, scientists are moving closer to treatments for ALS, Huntington's disease, and more. Don W. Cleveland, PhD, Department of Cellular and Molecular Medicine, UC San Diego joins William Mobley, MD, PhD to talk about how these drugs work and how they will impact patient care. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 32505]

Can we turn off the genes responsible for neurodegenerative diseases? Designer DNA drugs are making this possible. By identifying and targeting the genes that drive disease, scientists are moving closer to treatments for ALS, Huntington's disease, and more. Don W. Cleveland, PhD, Department of Cellular and Molecular Medicine, UC San Diego joins William Mobley, MD, PhD to talk about how these drugs work and how they will impact patient care. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 32505]

Can we turn off the genes responsible for neurodegenerative diseases? Designer DNA drugs are making this possible. By identifying and targeting the genes that drive disease, scientists are moving closer to treatments for ALS, Huntington's disease, and more. Don W. Cleveland, PhD, Department of Cellular and Molecular Medicine, UC San Diego joins William Mobley, MD, PhD to talk about how these drugs work and how they will impact patient care. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 32505]